Twenty First Centy Fox Cl A (FOXA) Shareholder M&R Capital Management Increased Its Stake by $428,570; Gilead Sciences (GILD) Shares Rose While Cabot-Wellington Has Trimmed Stake by $408,960

April 20, 2018 - By Michael Collier

Twenty-First Century Fox, Inc. (NASDAQ:FOXA) Logo

M&R Capital Management Inc increased its stake in Twenty First Centy Fox Inc Cl A (FOXA) by 4.93% based on its latest 2017Q4 regulatory filing with the SEC. M&R Capital Management Inc bought 12,605 shares as the company’s stock rose 3.52% while stock markets declined. The institutional investor held 268,208 shares of the consumer services company at the end of 2017Q4, valued at $9.24M, up from 255,603 at the end of the previous reported quarter. M&R Capital Management Inc who had been investing in Twenty First Centy Fox Inc Cl A for a number of months, seems to be bullish on the $68.61B market cap company. The stock decreased 0.29% or $0.11 during the last trading session, reaching $37.2. About 8.31M shares traded. Twenty-First Century Fox, Inc. (NASDAQ:FOXA) has risen 14.36% since April 20, 2017 and is uptrending. It has outperformed by 2.81% the S&P500.

Cabot-Wellington Llc decreased its stake in Gilead Sciences (GILD) by 4.03% based on its latest 2017Q4 regulatory filing with the SEC. Cabot-Wellington Llc sold 5,760 shares as the company’s stock rose 1.93% while stock markets declined. The hedge fund held 137,230 shares of the health care company at the end of 2017Q4, valued at $9.83 million, down from 142,990 at the end of the previous reported quarter. Cabot-Wellington Llc who had been investing in Gilead Sciences for a number of months, seems to be less bullish one the $97.06B market cap company. The stock decreased 1.64% or $1.24 during the last trading session, reaching $74.44. About 3.46 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 20, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Buy” rating by William Blair on Wednesday, June 14. Citigroup downgraded the shares of GILD in report on Wednesday, February 8 to “Neutral” rating. The firm has “Buy” rating by Maxim Group given on Thursday, November 30. On Wednesday, July 29 the stock rating was maintained by Needham with “Buy”. RBC Capital Markets maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, November 2. RBC Capital Markets has “Outperform” rating and $90 target. The firm has “Outperform” rating given on Wednesday, July 29 by RBC Capital Markets. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Tuesday, September 5 by Credit Suisse. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Tuesday, October 25 by Jefferies. Credit Suisse maintained the stock with “Hold” rating in Wednesday, January 3 report. The firm has “Buy” rating given on Tuesday, January 30 by Citigroup.

Cabot-Wellington Llc, which manages about $846.57 million and $164.34 million US Long portfolio, upped its stake in Ishares Core Msci Eafe (IEFA) by 23,680 shares to 481,760 shares, valued at $31.84M in 2017Q4, according to the filing.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.23, from 1.03 in 2017Q3. It dived, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. 18,312 were accumulated by Drw Secs Lc. Cognios Cap Lc holds 0.71% or 26,195 shares. Howard Hughes Med Institute reported 0.93% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Steinberg Global Asset Management holds 0.13% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 12,653 shares. Mckinley Carter Wealth Services stated it has 4,490 shares or 0.11% of all its holdings. Sns Fincl Group Inc Limited Co stated it has 0.49% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Old Natl Comml Bank In reported 0.11% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Griffin Asset Management has invested 0.35% in Gilead Sciences, Inc. (NASDAQ:GILD). Walleye Trading Llc accumulated 7,733 shares. 198,750 are owned by Skba Capital. Greylin Invest Mangement holds 0.76% or 48,837 shares. Foster And Motley reported 0.1% stake. 35,891 are held by Private Advisor Gp Ltd Liability Corporation. Cohen Klingenstein Lc reported 13,184 shares. Atria Invs Lc holds 0.25% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 69,230 shares.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on May, 1 after the close. They expect $1.59 EPS, down 27.73% or $0.61 from last year’s $2.2 per share. GILD’s profit will be $2.07B for 11.70 P/E if the $1.59 EPS becomes a reality. After $1.60 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -0.63% negative EPS growth.

Since January 2, 2018, it had 0 insider buys, and 17 sales for $39.51 million activity. Washington Robin L had sold 5,000 shares worth $401,566 on Wednesday, February 21. 50,000 shares were sold by MARTIN JOHN C, worth $4.18 million. $8.02 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares were sold by Meyers James R. Alton Gregg H sold $1.18 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, February 20. Shares for $4.68M were sold by WILSON GAYLE E on Friday, February 9.

Among 34 analysts covering Twenty-First Century Fox Inc (NASDAQ:FOXA), 22 have Buy rating, 1 Sell and 11 Hold. Therefore 65% are positive. Twenty-First Century Fox Inc had 101 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, June 12 by Pivotal Research. On Wednesday, August 9 the stock rating was maintained by RBC Capital Markets with “Buy”. On Tuesday, January 9 the stock rating was downgraded by Pivotal Research to “Hold”. The stock has “Buy” rating by RBC Capital Markets on Thursday, October 12. Pivotal Research maintained the stock with “Buy” rating in Thursday, August 10 report. On Friday, June 16 the stock rating was maintained by BMO Capital Markets with “Buy”. The firm has “Hold” rating by BMO Capital Markets given on Monday, December 18. The company was maintained on Wednesday, November 4 by Topeka Capital Markets. The firm earned “Buy” rating on Tuesday, October 20 by Pivotal Research. The stock has “Hold” rating by Needham on Friday, September 8.

M&R Capital Management Inc, which manages about $538.18 million and $431.40M US Long portfolio, decreased its stake in Visa Inc Com Cl A (NYSE:V) by 7,424 shares to 97,044 shares, valued at $11.05 million in 2017Q4, according to the filing. It also reduced its holding in Shire Plc Sponsored Adr (NASDAQ:SHPG) by 22,702 shares in the quarter, leaving it with 4,205 shares, and cut its stake in Qualcomm Inc Com (NASDAQ:QCOM).

Twenty-First Century Fox, Inc. (NASDAQ:FOXA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts